Saudi’s SAJA buys 51% stake in Biopharm

Saudi Arabia’s SAJA Pharma bought a 51% stake in Egyptian pharma company Biopharm, according to Al Borsa. The acquisition, whose was not revealed, was followed by an additional EGP 132.6 mn by SAJA into the company. The move comes as part of a strategy to increase their presence in Egypt. Baker and Mckenzie was the legal advisor on the transaction.